Astrazeneca Pharma India Ltd
₹6031.50
-407 (6.32%)
Sun, 22 Nov 2026, 11:05 am
Astrazeneca Pharma India Share Price Live Chart
1 Day
-407 (6.32%)
No Result Found
Summary
Market Cap (in Cr)
15396.25
Net Profit (in Cr)
187.52
P/B
22.23
Sector P/E
51.77
P/E
103.45
EV/EBITDA
66.82
Debt/Equity (Industry)
0.08
Interest Cover (Industry)
121.74
ROCE (Industry)
21.63
RONW (Industry)
17.09
ROE
22.82
ROCE
27.86
Debt/Equity
0.09
EPS (TTM)
75.29
Dividend Yield
0.58
Book Value
351.57
Interest Cover
57.17
Shareholding
| Shareholders | SEPT 2026 | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|---|---|
| Promoters | 75 | 75 | 75 | 75 | 75 |
| FII | 2.64 | 2.68 | 2.78 | 2.71 | 2.74 |
| DII | 7.09 | 6.08 | 5.80 | 5.56 | 5.26 |
| Public | 15.27 | 16.24 | 16.42 | 16.73 | 17.00 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 7654.83 | 6894.83 | 6629.67 | 6134.83 | 5869.67 | 5374.83 | 4614.83 |
| Fibonacci | 6894.83 | 6604.51 | 6425.15 | 6134.83 | 5844.51 | 5665.15 | 5374.83 |
| Camarilla | 6573.50 | 6503.83 | 6434.17 | 6134.83 | 6294.83 | 6225.17 | 6155.50 |
Pivots Level: Classic
R3
+1520
7654.83
R2
+760
6894.83
R1
+494.83
6629.67
S1
-265.17
5869.67
S2
-760
5374.83
S3
-1520
4614.83
Moving Average
Period
Value
10-EMA
6190.34
20-EMA
6218.25
30-EMA
6258.03
50-EMA
6418.47
100-EMA
6878.89
200-EMA
7445.70
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 05 Nov 2026 | board-meetings | Quarterly Results | |
| 18 Jul 2026 | agm | ||
| 26 May 2026 | dividend | ₹36.00 Dividend /Share | 31 Jul 2026 |
| 26 May 2026 | board-meetings | Accounts, Quarterly Results, Final Dividend | |
| 11 Feb 2026 | board-meetings | Quarterly Results | |
| 07 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 28 Jul 2025 | agm | ||
| 18 Jun 2025 | dividend | Dividend - Rs. - 32 | 18 Jul 2025 |
| 30 May 2025 | dividend | ₹32.00 Dividend /Share | 18 Jul 2025 |
| 16 Jul 2024 | agm |
Peer Comparison
Astrazeneca Pharma India Ltd
Laurus Labs Ltd
Divis Laboratories Ltd
Zydus Lifesciences Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Astrazeneca Pharma India Ltd About
Astrazeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company.
Industry
Pharmaceuticals - Multinational
Founded
1979
Headquarters
CEO
Shilpa Divekar Nirula
Employees
Contact
Website
http://www.astrazeneca.in
comp.secy@astrazeneca.com
Phone
91-080-67748000
Location
Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road, Bangalore, Karnataka, 560045
Astrazeneca Pharma India Ltd Company History
| Year | History |
|---|---|
| 2018 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 125166 | 7887.16 | 07 Oct 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 125166 | 7884.41 | 07 Oct 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 127119 | 7802 | 30 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 127119 | 7804.96 | 30 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 131308 | 7499.17 | 24 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 131308 | 7506.36 | 24 Sept 2024 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 74097 | 3152.55 | 19 Sept 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 6542 | 3152.55 | 19 Sept 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 6542 | 3152.55 | 19 Sept 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 74097 | 3152.55 | 19 Sept 2022 |
Frequently Asked Questions
1.What is the stock price of Astrazeneca Pharma India Ltd?
As of 22/11/2026 at 4:35 PM, Astrazeneca Pharma India Ltd shares are trading at ₹6031.50.
2.What is the market cap. of Astrazeneca Pharma India Ltd?
As of 22/11/2026, the market capitalization of Astrazeneca Pharma India Ltd is ₹15,097.50 crore.
3.When was Astrazeneca Pharma India Ltd founded?
Astrazeneca Pharma India Ltd was founded in 1979.
4.What are the P/E and P/B ratios of Astrazeneca Pharma India Ltd?
As of 22/11/2026, Astrazeneca Pharma India Ltd has a P/E ratio of 84.84 and a P/B ratio of 22.23.
5.How can I buy shares of Astrazeneca Pharma India Ltd?
You can buy shares of Astrazeneca Pharma India Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Astrazeneca Pharma India Ltd?
As of September,2026, promoters hold 75.00% in Astrazeneca Pharma India Ltd, while FIIs, DIIs and public shareholders hold 2.64%, 7.09% and 15.27%, respectively.
7.Does Astrazeneca Pharma India Ltd pay dividends?
Yes, Astrazeneca Pharma India Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹36.00 Dividend /Share per share.
8.What is the dividend yield of Astrazeneca Pharma India Ltd?
As of 22 November, 2026, the dividend yield of Astrazeneca Pharma India Ltd stands at 0.60%.
9.What are the latest financial results of Astrazeneca Pharma India Ltd?
For the financial year ended March 2025, Astrazeneca Pharma India Ltd reported revenue of ₹1,716.00 crore and a net profit of ₹116.00 crore.
10.What is the Stock symbol of Astrazeneca Pharma India Ltd?
ASTRAZEN is the stock symbol of Astrazeneca Pharma India Ltd.
11.Who is the CEO of Astrazeneca Pharma India Ltd?
The CEO of Astrazeneca Pharma India Ltd is Shilpa Divekar Nirula.